相关实验视频
Updated: Jan 13, 2026

10:31
Antigenic Liposomes for Generation of Disease-specific Antibodies
Published on: October 25, 2018
12.8K
奥马利祖马布用于食物过敏
1Division of Pediatric Allergy, Immunology and Rheumatology, Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Current opinion in allergy and clinical immunology
|October 29, 2025
概括
现在Omalizumab被FDA批准用于减少意外暴露于食物过敏原的过敏反应. 研究表明,它增加了对多种食物的耐受性,可以单独使用或与口服免疫疗法一起用于食物过敏管理.
科学领域:
- 免疫学 免疫学 免疫学
- 过敏学 过敏学
- 药理学 药理学是指药理学的学科.
背景情况:
- 食物过敏影响全球数百万人,需要先进的治疗选择.
- 意外接触过敏原可以引发严重反应,造成严重的健康风险.
- 目前的管理往往依赖于严格的避免和紧急治疗.
研究的目的:
- 审查目前支持FDA批准对食物过敏治疗的奥马利祖马布的证据.
- 检查正在进行的研究奥马利祖马布的疗效和最佳使用在食物过敏.
- 评估奥马利祖马布作为独立治疗和与其他治疗结合的作用.
主要方法:
- 关键临床试验的审查,包括OUtMATCH试验.
- 对奥马利祖马布对反应值和饮食消费的影响数据的分析.
- 对口服免疫疗法 (OIT) 的比较研究的评估.
主要成果:
- OUtMATCH试验证实了奥马利祖马布在增加对多种食物过敏原的耐受性方面的有效性.
- 第三阶段的OUtMATCH数据表明,奥马利祖马布促进了食中增加过敏原食品的摄入量.
- 目前正在进行的研究正在比较奥马利祖马布对OIT的有效性及其与OIT的协同效应.
结论:
- 奥马利祖马布为受食物过敏影响的个人和家庭提供了一个重要的新治疗途径.
- 在了解奥马利祖马布的机制和临床应用方面取得了重大进展.
- 进一步的研究将完善奥马利祖马布在综合性食物过敏管理策略中的最佳整合.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
Allergic Drug Reactions
1.3K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.3K
Allergic Reactions
32.0K
Overview
32.0K
Myasthenia Gravis: Overview and Treatment
2.8K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.8K
Antiasthma Drugs: Methylxanthines
1.6K
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
1.6K

